4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 470.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 885.00
  • 52 Week Low: 440.83
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 76
  • Market Cap: £73.03m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
20-May-26 Buy Amy Walker 509.00p 1,863 £9,482.67
13-Feb-26 Buy Amy Walker 586.08p 2,650 £15,531.12
10-Feb-26 Buy Hansjörg Plaggemars 585.00p 1,000 £5,850.00
10-Feb-26 Buy Heikki Lanckriet 575.82p 3,000 £17,274.60
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
10-Feb-26 Buy Heikki Lanckriet 575.82p 3,000 £17,274.60
13-Feb-26 Buy Amy Walker 586.08p 2,650 £15,531.12
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
20-May-26 Buy Amy Walker 509.00p 1,863 £9,482.67
10-Feb-26 Buy Hansjörg Plaggemars 585.00p 1,000 £5,850.00

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,122,688 £5,276,634
Amy Walker 48,529 £228,086
Hansjörg Plaggemars 7,667 £36,035

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £24,062,792
DELPHI Unternehmensberatung AG 5,119,743 £24,062,792
4bb AG 5,115,852 £24,044,504
M&G Plc 4,627,741 £21,750,383
Elevage Medical Technologies Holdings 4,627,741 £21,750,383
Deutsche Balaton AG 4,432,637 £20,833,394
2invest AG 2,229,083 £10,476,690
Sparta AG 1,351,718 £6,353,075
Latonba AG 778,891 £3,660,788
Franciscus De Busschere 537,255 £2,525,098

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 470.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 885.00
52 Week Low 440.83
Volume 76
Shares Issued 15.54m
Market Cap £73.03m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 24-Aug-2026

Time Volume / Share Price
15:58 9 @ 490.00p
12:19 9 @ 490.00p
10:58 9 @ 490.00p
10:57 9 @ 490.00p
08:23 9 @ 490.00p

4basebio Key Personnel

CFO David John Roth
CEO Amy Walker
COO Scott Lorimer

Top of Page